← Leaderboards
Andrea G Nackley
Univ Of North Carolina Chapel Hill
$13,815,478
Attributed
$16,217,637
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2010–24$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$16,217,637 · 11
By mechanism
R01$10,511,046 · 4
R61$2,270,933 · 2
P01$1,994,204 · 2
R33$695,453 · 1
R56$586,001 · 1
R03$160,000 · 1
Top collaborators
- Yong Chen1 shared
- Chunyang Jin1 shared
- Gary D Slade1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Denniz A Zolnoun$1,307,597
- Samuel Arbes$42,437,176
- Inna Evgenievna Tchivileva$1,235,635
- Anne E. Sanders$2,143,910
- Richard Ohrbach$3,074,138
Others in their field
Top investigators on “Pain”
- Emer Leahy · Psychogenics, Inc.$49,781,254
- Lynn Larson Debar · Kaiser Foundation Research Institute$37,527,482
- J Richard Landis · University Of Pennsylvania$34,799,488
- Clifford J Woolf · Boston Children'S Hospital$30,992,766
- Emeran A Mayer · University Of California Los Angeles$29,229,798
- Pamela Susan Douglas · Duke University$28,862,172
Research focus
PainSiteCytokineExhibitsPathway InteractionsInsightPeripheralFibromyalgiaHealthcareMediatingReportingPersistent PainComplexChronicTemporomandibular Joint DisordersAffectInflammatorySyndromeEnzymesBiological MarkersLeadCatecholaminesMolecularAnimal Model
Grant awards (33)
Identification and validation of LPA/LPAR signaling as a target for the treatment of temporomandibular disorder pain$2,372,116
R01 · FY2024 · DE
A novel clinically- relevant mouse model of chronic overlapping pain conditions for screening analgesics$357,278
R33 · FY2024 · NS · contact PI
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments (Vestibulodynia: UPDATe)$257,632
R01 · FY2024 · HD · contact PI
A novel clinically- relevant mouse model of chronic overlapping pain conditions for screening analgesics$52,433
R33 · FY2024 · NS · contact PI
Development of Adrb3 Antagonists for the Treatment of Pain$1,846,202
R61 · FY2023 · NS · contact PI
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments (Vestibulodynia: UPDATe)$738,743
R01 · FY2023 · HD · contact PI
Defining the role of peripheral Adrb3 in chronic pain and inflammation$519,518
R01 · FY2023 · NS · contact PI
A novel clinically- relevant mouse model of chronic overlapping pain conditions for screening analgesics$285,742
R33 · FY2023 · NS · contact PI
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics$71,998
R61 · FY2023 · NS · contact PI
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments (Vestibulodynia: UPDATe)$753,449
R01 · FY2022 · HD · contact PI
Defining the role of peripheral Adrb3 in chronic pain and inflammation$519,518
R01 · FY2022 · NS · contact PI
A novel clinically- relevant mouse model of chronic overlapping pain conditions for screening analgesics$352,733
R61 · FY2022 · NS · contact PI
Defining the role of peripheral Adrb3 in chronic pain and inflammation$534,634
R01 · FY2021 · NS · contact PI
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments (Vestibulodynia: UPDATe)$768,005
R01 · FY2020 · HD · contact PI
Defining the role of peripheral Adrb3 in chronic pain and inflammation$524,671
R01 · FY2020 · NS · contact PI
Resolving functional pain by complementary approaches$264,402
P01 · FY2020 · AT · contact PI
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments (Vestibulodynia: UPDATe)$781,299
R01 · FY2019 · HD · contact PI
Defining the role of peripheral Adrb3 in chronic pain and inflammation$525,095
R01 · FY2019 · NS · contact PI
Defining the role of adipocyte Adrb3 in chronic pain$80,250
R03 · FY2019 · NS · contact PI
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments (Vestibulodynia: UPDATe)$804,598
R01 · FY2018 · HD · contact PI
Defining the role of adipocyte Adrb3 in chronic pain$79,750
R03 · FY2018 · NS · contact PI
Proteins, MicroRNAs and Genes Associated with TMD and Overlapping Pain Conditions$586,001
R56 · FY2016 · DE · contact PI
Persistent COMT-dependent Pain: Role of beta-adrenergic Receptors$353,899
R01 · FY2014 · NS · contact PI
Molecular Profiling Core$323,906
P01 · FY2014 · NS · contact PI
Molecular Profiling Core$426,969
P01 · FY2013 · NS · contact PI
Persistent COMT-dependent Pain: Role of beta-adrenergic Receptors$362,902
R01 · FY2013 · NS · contact PI
Persistent COMT-dependent Pain: Role of beta-adrenergic Receptors$376,064
R01 · FY2012 · NS · contact PI
Molecular Profiling Core$284,648
P01 · FY2012 · NS · contact PI
Molecular Profiling Core$49,428
P01 · FY2012 · NS · contact PI
Persistent COMT-dependent Pain: Role of beta-adrenergic Receptors$18,590
R01 · FY2012 · NS · contact PI
Molecular Profiling Core$310,983
P01 · FY2011 · NS · contact PI
Persistent COMT-dependent Pain: Role of beta-adrenergic Receptors$300,313
R01 · FY2011 · NS · contact PI
Molecular Profiling Core$333,868
P01 · FY2010 · NS · contact PI